119 related articles for article (PubMed ID: 6378561)
1. Integrated pharmacokinetic-dynamic modeling of drugs acting on the CNS.
Paalzow LK
Drug Metab Rev; 1984; 15(1-2):383-400. PubMed ID: 6378561
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic modeling in vivo.
Holford NH; Sheiner LB
Crit Rev Bioeng; 1981; 5(4):273-322. PubMed ID: 7023829
[TBL] [Abstract][Full Text] [Related]
3. Review on correlation between pharmacologic response and drug disposition.
Ritschel WA; Hussain A
Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):627-40. PubMed ID: 6392792
[TBL] [Abstract][Full Text] [Related]
4. Quantitative relationships between dynamics and kinetics of drugs: a systems dynamics approach.
van Rossum JM; Burgers JP
Drug Metab Rev; 1984; 15(1-2):365-82. PubMed ID: 6378560
[TBL] [Abstract][Full Text] [Related]
5. Uses of pharmaco-EEG and pharmacokinetic-pharmacodynamic modeling in the clinical scenario.
Barbanoj MJ; Valle M; Kulisevsky J; Pérez V; Gambús P
Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():139-44. PubMed ID: 12575481
[TBL] [Abstract][Full Text] [Related]
6. Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept.
Reichel A
Chem Biodivers; 2009 Nov; 6(11):2030-49. PubMed ID: 19937839
[TBL] [Abstract][Full Text] [Related]
7. [Rational posology and drug dosage].
Riant P; Albengres E; Barre J; Tillement JP
Ann Biol Clin (Paris); 1986; 44(1):15-24. PubMed ID: 3518550
[TBL] [Abstract][Full Text] [Related]
8. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
Gabrielsson J; Green AR
J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
[TBL] [Abstract][Full Text] [Related]
9. The time course of drug effects.
Al-Sallami HS; Pavan Kumar VV; Landersdorfer CB; Bulitta JB; Duffull SB
Pharm Stat; 2009; 8(3):176-85. PubMed ID: 19626596
[TBL] [Abstract][Full Text] [Related]
10. Principles of pharmacodynamics and their applications in veterinary pharmacology.
Lees P; Cunningham FM; Elliott J
J Vet Pharmacol Ther; 2004 Dec; 27(6):397-414. PubMed ID: 15601436
[TBL] [Abstract][Full Text] [Related]
11. Target-mediated drug disposition and dynamics.
Mager DE
Biochem Pharmacol; 2006 Jun; 72(1):1-10. PubMed ID: 16469301
[TBL] [Abstract][Full Text] [Related]
12. Nociceptive stimulus modality-related difference in pharmacokinetic-pharmacodynamic modeling of morphine in the rat.
Shang GW; Liu DN; Yan LH; Cui XY; Zhang KP; Qi C; Chen J
Pharmacol Biochem Behav; 2006 Oct; 85(2):464-73. PubMed ID: 17126387
[TBL] [Abstract][Full Text] [Related]
13. Saliva-plasma drug concentration ratios during absorption: theoretical considerations and pharmacokinetic implications.
Posti J
Pharm Acta Helv; 1982; 57(3):83-92. PubMed ID: 7071071
[No Abstract] [Full Text] [Related]
14. Pharmaco-electroencephalography and pharmacokinetic/pharmacodynamic modeling in basic research: focus on human pharmacology.
Valle M; Barbanoj MJ; Jané F
Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():129-37. PubMed ID: 12575480
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics: current requirements and future perspectives from a regulatory point of view.
Shah RR
Xenobiotica; 1993 Nov; 23(11):1159-93. PubMed ID: 8310705
[TBL] [Abstract][Full Text] [Related]
16. Local controlled drug delivery to the brain: mathematical modeling of the underlying mass transport mechanisms.
Siepmann J; Siepmann F; Florence AT
Int J Pharm; 2006 May; 314(2):101-19. PubMed ID: 16647231
[TBL] [Abstract][Full Text] [Related]
17. Drug therapy in childhood: what has been done and what has to be done?
Bartels H
Pediatr Pharmacol (New York); 1983; 3(3-4):131-43. PubMed ID: 6677868
[TBL] [Abstract][Full Text] [Related]
18. Drug metabolism as a confounding factor in PK/PD population approaches.
Balant LP; Gex-Fabry M; Balant-Gorgia E
Therapie; 1996; 51(4):390-8. PubMed ID: 8953815
[TBL] [Abstract][Full Text] [Related]
19. Target-mediated drug disposition model: approximations, identifiability of model parameters and applications to the population pharmacokinetic-pharmacodynamic modeling of biologics.
Gibiansky L; Gibiansky E
Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):803-12. PubMed ID: 19505189
[TBL] [Abstract][Full Text] [Related]
20. In vitro measurements of metabolism for application in pharmacokinetic modeling.
Lipscomb JC; Poet TS
Pharmacol Ther; 2008 Apr; 118(1):82-103. PubMed ID: 18374419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
